HARROW
Live / Registered — Registered (as of 22 Sept 2026)
What this means for you
Registered since 22 Sept 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 Sept 2032: the §8 declaration of use).
Record
- Serial number
- 98402103
- Registration number
- 8451414
- Mark type
- Design + words
- Filed
- 12 Feb 2024
- Published for opposition
- 22 Oct 2024
- Registered
- 22 Sept 2026
- Next maintenance filing
- §8 declaration of use, due by 22 Sept 2032 (grace period to 22 Mar 2033)
- Attorney of record
- Laila S. Wolfgram
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical compositions for ophthalmological use
Owner
- Harrow IP, LLC, Nashville, TN, US
- Harrow IP, LLC, Nashville, TN, US
- Harrow IP, LLC, Nashville, TN, US
Prior registrations
Prosecution history
- 22 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 02 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Jun 2026 — USE AMENDMENT FILED
- 01 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Jun 2026 — TEAS STATEMENT OF USE RECEIVED
- 02 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Dec 2025 — SOU EXTENSION 2 GRANTED
- 01 Dec 2025 — SOU EXTENSION 2 FILED
- 01 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED